CXCR4 and breast cancer: Within the EP2 group genes associated with the promotion of an aggressive mesenchymal phenotype and EMT were upregulated and included MMPs, integrins, vimentin and CXCR4. The Willipinski et al. [92] study mentioned above also used protein-based assays to assess cell lines established from the DTCs of breast cancer patients.